🇺🇸 FDA

Company profile · Sponsor

Amicus

Amicus Therapeutics Europe Limited

EE9EA58 · EMA pharma GB
Pipeline
2
Drugs
0
Patents
0

Quick answer

Amicus (EE9EA58) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EE9EA58
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (2)

Search pipeline →

  1. AT2221, ATB200

    Amicus

    Adult Subjects With Late Onset Pompe Disease (LOPD)

    phase 3 small molecule active

    1 trial

  2. Migalastat Hydrochloride Dispersible Tablet

    Amicus

    Fabry disease

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Amicus?

Amicus (EE9EA58) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Amicus sponsor?

We track 2 ClinicalTrials.gov-linked programs for Amicus, including AT2221, ATB200 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Amicus company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.